“It’s a really, really big problem, not only for individual patients, but also for society.”
Penicillin, one of the scientific marvels of the 20th century, is currently losing a lot of battles it once won against bacterial infections. But scientists at the University of South Carolina have just reported a new approach to restoring its combat effectiveness, even against so-called “superbugs.”
Bacteria have been chipping away at the power of the penicillin family of drugs since their first wide-scale use as antibiotics in the 1940s. For example, the staph infection, brought about by the bacterium Staphylococcus aureus, was once readily treated with penicillin and its molecular cousins.
But that bug has changed. In the 1960s, a new strain arrived, termed MRSA for methicillin- (or sometimes multidrug-) resistant S. aureus. It has become a serious public health problem because the earliest deployed antibiotics are often useless against the new strain, and its prevalence has only increased since it was first observed. MRSA (pronounced mer-suh) is sometimes called a superbug because of the difficulty physicians have in treating infected patients.
The S. aureus microbe has evolved the MRSA strain by developing a variety of defenses against antibiotics to which they’ve been exposed. One of those defenses effectively neutralizes penicillin’s greatest strength.
That strength is its molecular core, a cyclic four-membered amide ring termed a beta-lactam. It is a common structural element of the penicillins, their synthetic and semi-synthetic derivatives, and other related molecules that constitute the broad family of drugs called the beta-lactam antibiotics. Just a few examples (of dozens) include amoxicillin, ampicillin and cefazolin.
The beta-lactam structure in a molecule is something that many bacteria don’t like at all. It greatly hinders their ability to reproduce by cell division, and so chemists have for years spent time making molecules that all contain the beta-lactam structural motif, but differ in the surrounding molecular “shrubbery.” Physicians heavily use the many versions of beta-lactam antibiotics to fight bacterial infections, and many have been retired because they’re no longer effective against the defenses bacteria have evolved in response.
One of the most effective bacterial defenses is an enzyme called beta-lactamase, which chews up the beta-lactam structure. Some bacteria, such as MRSA, have developed the ability to biosynthesize and release beta-lactamase when needed. It’s a devastating defense because it’s so general, targeting the common structural motif in all of the many beta-lactam antibiotics.
But that also creates the opportunity for a general approach to solving the problem, which is what Carolina’s Chuanbing Tang and colleagues just reported in the Journal of the American Chemical Society.
“Instead of developing new antibiotics, here we ask the question, ‘can we recycle the old antibiotics?’ ” he said. “With traditional antibiotics like penicillin G, amoxicillin, ampicillin and so on, can we give them new life?”
The approach pairs the drug with a protective polymer developed in Tang’s chemistry laboratory. In lab tests, graduate student Jiuyang Zhang prepared a cobaltocenium metallopolymer that greatly slowed the destructiveness of beta-lactamase on a model beta-lactam molecule (nitrocefin).
The interdisciplinary team, which included Mitzi Nagarkatti and Alan Decho, from the university’s School of Medicine and Arnold School of Public Health, respectively, also showed that the antimicrobial effectiveness of the four beta-lactams studied in detail was enhanced by the polymer. The enhancement was modest against two strains, but very pronounced with the hospital-associated strain of MRSA (HA-MRSA).
The metallopolymer by itself even demonstrated antimicrobial properties, lysing bacterial cells while leaving human red blood cells unaffected. By a variety of measures, the polymer was found to be nontoxic to human cells in laboratory tests.
The project is still far from clinical use, but Tang knows moving forward is imperative.
“In the United States every year, around 100,000 patients die of bacteria-induced infections,” Tang said. “And the problem is increasing because bacteria are building resistance.
“It’s a really, really big problem, not only for individual patients, but also for society.”
The Latest on: Superbug
[google_news title=”” keyword=”Superbug” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Superbug
- Midlands city named England's main hotspot for Victorian superbugon April 15, 2024 at 9:30 pm
A West Midlands city has been identified as a hotspot for a Victorian superbug. Birmingham had the highest number of tuberculosis cases last year, health data showed. The disease, associated with the ...
- Hospital sinks linked to multidrug-resistant bacteria spread: Details Insideon April 12, 2024 at 12:44 am
A research published in the American Journal of Infection Control (AJIC), found the reasons behind the months-long multispecies outbreak of superbug Carbapenemase Producing Entrerobacterales (CPE) ...
- Hospital Sinks: Prime Spot for Multidrug-Resistant Bacteriaon April 11, 2024 at 11:14 am
The risk of spread of multidrug-resistant bacteria is highest in hospital sinks, said a study on Thursday. The findings are based on a multispecies outbreak of superbug carbapenemase-producing ...
- Research Roundup: Superbug-fighting drugs, affordable green energy and anti-agingon April 7, 2024 at 10:36 pm
The The Daily’s academics desk gathers a weekly digest collecting some of the most impactful and interesting research publications and developments at Stanford. Read the latest in this week’s Research ...
- ‘Like the Day of the Triffids’: How a researcher saved her friend’s life from the ‘monster’ among uson April 6, 2024 at 8:55 am
When Troy complained on Facebook about something weird in his shoulder, one of his friends who took notice was pandemic-famous epidemiologist Catherine Bennett.
- Contact with young kids may be leading risk factor for pneumonia in older adultson April 4, 2024 at 8:33 am
Contact with pre-school and kindergarten-aged kids may be the leading transmission route for bacteria that can cause dangerous pneumonias in folks over 60.
- One dead in bacteria outbreak linked to eye drops from Indiaon April 3, 2024 at 11:41 am
One person has died and dozens more have been infected with antibiotic-resistant bacteria in an outbreak that has been linked to eye drops from India.Health officials said at least 52 people had been ...
- Brit dies from superbug as outbreak linked to bacteria-contaminated eye dropson April 3, 2024 at 10:52 am
AaCarb, Aacomer and Purpotics eye gels have been taken off supermarket shelves over concerns they are contaminated with an antibiotic resistant bug called Burkholderia cepacia bacteria ...
- One person dies and more fall ill after using contaminated eye dropson April 3, 2024 at 9:20 am
A person has died and dozens more have fallen ill after a ‘superbug’ outbreak linked to contaminated eye drops. The UK Health Security Agency (UKHSA) said three eye gels contained Burkholderia cepacia ...
- One Brit dead in superbug outbreak caused by contaminated EYE DROPS as others fall sick with blood poisoningon April 3, 2024 at 7:02 am
A ‘SUPERBUG’ outbreak linked to bacteria-contaminated eye drops has seen one Brit die and dozens more fall ill. The UK Health Security Agency (UKHSA) traced the outbreak back to three ...
via Bing News